[Retracted] PLGA/poloxamer nanoparticles loaded with EPAS1 siRNA for the treatment of pancreatic cancer <i>in vitro</i> and <i>in vivo</i>. This evidence concerns the gene EPAS1 and familial pancreatic carcinoma.